Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Goodwill & Intangibles (2017 - 2025)

Inmune Bio's Goodwill & Intangibles history spans 9 years, with the latest figure at $16.5 million for Q1 2025.

  • For Q1 2025, Goodwill & Intangibles changed 0.0% year-over-year to $16.5 million; the TTM value through Mar 2025 reached $16.5 million, changed 0.0%, while the annual FY2024 figure was $16.5 million, 0.0% changed from the prior year.
  • Goodwill & Intangibles for Q1 2025 was $16.5 million at Inmune Bio, roughly flat from $16.5 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $16.5 million in Q1 2021 and bottomed at $0.1 in Q4 2021.
  • The 5-year median for Goodwill & Intangibles is $16.5 million (2021), against an average of $15.5 million.
  • The largest annual shift saw Goodwill & Intangibles crashed 100.0% in 2021 before it soared 16513999900.0% in 2022.
  • A 5-year view of Goodwill & Intangibles shows it stood at $0.1 in 2021, then skyrocketed by 16513999900.0% to $16.5 million in 2022, then changed by 0.0% to $16.5 million in 2023, then changed by 0.0% to $16.5 million in 2024, then changed by 0.0% to $16.5 million in 2025.
  • Per Business Quant, the three most recent readings for INMB's Goodwill & Intangibles are $16.5 million (Q1 2025), $16.5 million (Q4 2024), and $16.5 million (Q3 2024).